Innova Captab Limited (BOM:544067)

Market Cap	49.93B -5.8%
Revenue (ttm)	16.30B +31.1%
Net Income	1.41B +9.9%
EPS	24.63 +9.9%
Shares Out	n/a
PE Ratio	35.43
Forward PE	26.31
Dividend	2.00 (0.23%)
Ex-Dividend Date	Jan 30, 2026

Volume	2,126
Open	874.95
Previous Close	871.75
Day's Range	859.30 - 885.00
52-Week Range	608.25 - 1,002.95
Beta	n/a
Analysts	Strong Buy
Price Target	1,078.50 (+25.07%)
Earnings Date	May 7, 2026

About Innova Captab

Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also offers various generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinoly...

• Industry: Pharmaceutical Preparations
• Founded: 2005
• Employees: 1,600
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544067

Financial Performance

In fiscal year 2026, Innova Captab's revenue was 16.30 billion, an increase of 31.06% compared to the previous year's 12.44 billion. Earnings were 1.41 billion, an increase of 9.87%.

Analyst Summary

According to 2 analysts, the average rating for 544067 stock is "Strong Buy." The 12-month stock price target is ₹1,079, which is an increase of 25.07% from the latest price.

Price Target

₹1,079

(25.07% upside)

Analyst Consensus: Strong Buy